Journal Article DESY-2014-01257

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro

 ;

2013
RSC Publ. Cambridge

Metallomics 5(6), 597 -614 () [10.1039/c3mt20261e]
 GO

This record in other databases:        

Please use a persistent id in citations: doi:

Abstract: X-ray absorption spectroscopy (XAS) and micro-synchrotron based X-ray fluorescence (micro-SXRF) are element specific spectroscopic techniques and have been proven to be valuable tools for the investigation of changes in the chemical environment of metal centres. XAS allows the determination of the oxidation state, the coordination motif of the probed element, the identity and the number of adjacent atoms and the absorber–ligand distances. It is further applicable to nearly all types of samples independent of their actual physical state (solid, liquid, gaseous) down to μM concentrations. Micro-SXRF can provide information on the distribution and concentration of multiple elements within a sample simultaneously, allowing for the chemical state of several elements within subcellular compartments to be probed. Modern third generation synchrotrons offer the possibility to investigate the majority of the biologically relevant elements. The biological mode of action of metal-based compounds often involves interactions with target and/or transport molecules. The presence of reducing agents may also give rise to changes in the coordination sphere and/or the oxidation state. XAS and micro-SXRF are ideal techniques for investigating these issues. This tutorial review introduces the use of XAS and micro-SXRF techniques into the field of inorganic medicinal chemistry. The results obtained for platinum, ruthenium, gallium, gold and cobalt compounds within the last few years are presented.

Classification:

Note: (c) The Royal Society of Chemistry; Post referee fulltext in progress; Embargo 12 months from publication

Contributing Institute(s):
  1. DOOR-User (DOOR)
Research Program(s):
  1. DORIS Beamline D2 (POF2-54G13) (POF2-54G13)
Experiment(s):
  1. DORIS Beamline D2 (DORIS III)

Appears in the scientific report 2013
Database coverage:
Medline ; BIOSIS Previews ; JCR ; NCBI Molecular Biology Database ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
>HAS-User > HAS-User
Public records
Publications database

 Record created 2014-01-21, last modified 2025-07-30


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)